Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
Other Long-Term Assets
Santen Pharmaceutical Co Ltd
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Other Long-Term Assets
¥19.8B
|
CAGR 3-Years
43%
|
CAGR 5-Years
41%
|
CAGR 10-Years
11%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Long-Term Assets
¥445.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
6%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Long-Term Assets
¥440.1B
|
CAGR 3-Years
40%
|
CAGR 5-Years
34%
|
CAGR 10-Years
12%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Long-Term Assets
¥150.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
34%
|
CAGR 10-Years
12%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Long-Term Assets
¥129.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
|
Astellas Pharma Inc
TSE:4503
|
Other Long-Term Assets
¥64.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
2%
|
See Also
What is Santen Pharmaceutical Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
19.8B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Other Long-Term Assets amounts to 19.8B JPY.
What is Santen Pharmaceutical Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
11%
Over the last year, the Other Long-Term Assets growth was 147%. The average annual Other Long-Term Assets growth rates for Santen Pharmaceutical Co Ltd have been 43% over the past three years , 41% over the past five years , and 11% over the past ten years .